Xilio Therapeutics (XLO) stock
Breakaway doesn't score XLO. It is too thinly traded for a fair Quality Score.
Follow XLO's news. Pro members can get an alert when Xilio Therapeutics files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.
What's next for XLO, and how long its cash lasts
Next step the company has named
Cash runway
About 8 quarters
Dilution on the horizon
- Shelf registration (S-3, filed May 12, 2026)
- At-the-market share sales program (S-3, filed May 12, 2026)
Insiders
Director James Samuel Shannon bought 5,000 shares on Mar 26. 2 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
XLO's latest filings
- Quarterly report
- Xilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates
- 2 insider filings
Why XLO isn't scored
The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. XLO trades about 17,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.
Straight AnswersStraight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.